Posts by Alison S. Witkin, MD
Studies Work to Improve Pulmonary Hypertension and HHT Care
Research at Massachusetts General Hospital seeks to expand indications for pulmonary hypertension treatments, cure chronic thromboembolic pulmonary hypertension with novel surgeries and help primary care providers treat hereditary hemorrhagic telangiectasia.
Right Ventricular Dysfunction May Prove to Be Common with COVID-19
Massachusetts General Hospital clinicians note that, to date, there is no convincing evidence that right ventricular failure in patients with COVID-19 has any novel features.
Antibody Testing Vital to Managing the COVID-19 Pandemic
Massachusetts General Hospital clinicians believe serologic testing will be a critical tool in combating the COVID-19 pandemic.
RV Failure in COVID-19
In this FLARE, we review the epidemiology and pathophysiology of critical illness-associated RV dysfunction to inform the management of patients suffering from severe COVID-19.
Using Antibody Tests for COVID-19
Antibody testing holds promise as a method by which to identify the true past incidence or current prevalence of SARS-CoV-2 infection.
Dr. Witkin’s clinical and research interests focus on patients with pulmonary hypertension, and she is the associate director of the Pulmonary Hypertension and Thromboendarterectomy Program at Mass General. She has a particular interest in both acute and chronic thromboembolic disease. She is a member of the Mass General Pulmonary Embolism Response Team (PERT) and serves as the co-chair of the communications committee for the National PERT Consortium. She is particularly interested in the recovery from acute PE and sees patients in a follow up PE clinic to help with early identification of patients with incomplete recovery.